Francesca Barone

Company: Candel Therapeutics

Job title: Chief Scientific Officer

Seminars:

Development of In Vivo Models to Study Oncolytic Viral Therapies in Combination Treatments 8:35 am

• Overcoming the complexity of tumour biology and complex therapeutic interactions • Spotlighting techniques to engineer mouse cell lines to better study oncolytic viruses • Understanding strategies to combine oncolytic viruses with CAR-T cells for therapyRead more

day: Conference Day Two